Please ensure Javascript is enabled for purposes of website accessibility

Why Tilray Shares Are Falling Today

By Keith Speights - Mar 3, 2020 at 11:29AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors weren't happy with the Canadian cannabis producer's Q4 update.

What happened

Shares of Tilray (TLRY) had fallen 11.5% as of 11:03 a.m. EST on Tuesday. The drop resulted from the Canadian cannabis producer's disappointing fourth-quarter update after the market closed on Monday.

Tilray announced Q4 revenue of $23 million, down 8% from the previous quarter. It also reported a big net loss in Q4 of $219.1 million, or $2.14 per share. This loss was significantly worse than the company's net loss in the third quarter of 2019.

Blue gloved hand holding a cannabis leaf in front of a Canadian flag

Image source: Getty Images.

So what

The main problem for Tilray is that the trends aren't its friends. Both the top and bottom lines for the company are heading in the wrong direction.

Tilray's primary issue on the top line is that its bulk cannabis revenue plunged nearly 61% from Q3. Its medical cannabis sales in Canada and in international markets also declined from the previous quarter. These headwinds weren't enough to offset a 7% quarter-over-quarter increase in revenue from the Canadian adult-use recreational marijuana market.

But the biggest challenge for Tilray overall is that it continues to lose a boatload of money. The company's deteriorating bottom line is concerning. Granted, there were some one-time items that caused the net loss in Q4 to be worse than it would otherwise have been. Tilray recorded over $68 million in inventory adjustments and wrote down over $112 million related to its collaboration with Authentic Brands Group. But the net loss would have been substantial even without these items. 

Now what

Tilray could benefit from some developments that are good for all Canadian marijuana stocks. Ontario is beginning to issue more retail cannabis licenses. The Cannabis 2.0 market for cannabis derivatives is just cranking up. In addition, the company has cut costs significantly as part of a restructuring announced last month. Still, expect Tilray stock to remain highly volatile this year.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Tilray Stock Quote

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.